Rapid Improvement of the Performance Status and Reduction of the Tumor Size in KRAS-Mutated Colorectal Cancer Patient Receiving Binimetinib, Hydroxychloroquine, and Bevacizumab

by Sergey V. Orlov, Magaripa A. Urtenova, Maria A. Sviridenko, Denis V. Nesterov, Tatiana N. Sokolova, Evgeny N. Imyanitov
Published 2020-08-01